Inovio Pharma (INO) Swings to Q3 Profit
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $11.07 +14.83%
EPS Growth %: -625.0%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
CPSS, HARL, MCET, More
EPS Growth %: -625.0%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
CPSS, HARL, MCET, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of $0.07, versus ($0.12) reported last year. Revenue for the quarter came in at $24.18 million, versus $1.84 million reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First Industrial Realty (FR) Tops Q1 EPS by 21c
- Equifax (EFX) Tops Q1 EPS by 6c, Misses on Revenue; Offers Guidance
- CSX reiterates FY outlook as Q1 results top estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
